ADVANCED TISSUE SCIENCES INC
10-Q, EX-27, 2000-08-09
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ADVANCED TISSUE SCIENCES INC, 10-Q, EX-3.(II), 2000-08-09
Next: ROYAL BODYCARE INC/NV, 10-Q, 2000-08-09



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
    This schedule contains summary financial information extracted from the
Form 10-Q for the quarter ended June 30, 2000 and is qualified in its entirety
by reference to such financial statements.
</LEGEND>
<CIK>                         0000829549
<NAME>                        ADVANCED TISSUE SCIENCES, INC.
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                             DEC-31-2000
<PERIOD-START>                                JAN-01-2000
<PERIOD-END>                                  JUN-30-2000
<CASH>                                             17,878
<SECURITIES>                                        4,992
<RECEIVABLES>                                       6,698
<ALLOWANCES>                                            0
<INVENTORY>                                           183
<CURRENT-ASSETS>                                   31,163
<PP&E>                                             33,139
<DEPRECIATION>                                    (17,851)
<TOTAL-ASSETS>                                     49,504
<CURRENT-LIABILITIES>                              20,196
<BONDS>                                             7,692
                                   0
                                             0
<COMMON>                                              598
<OTHER-SE>                                         20,679
<TOTAL-LIABILITY-AND-EQUITY>                       49,504
<SALES>                                             6,618
<TOTAL-REVENUES>                                   13,673
<CGS>                                               6,618
<TOTAL-COSTS>                                      22,397
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                   (7,255)
<INTEREST-EXPENSE>                                   (924)
<INCOME-PRETAX>                                   (15,727)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                               (15,727)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                      (15,727)
<EPS-BASIC>                                          (.27)
<EPS-DILUTED>                                        (.27)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission